JP2014122240A5 - - Google Patents

Download PDF

Info

Publication number
JP2014122240A5
JP2014122240A5 JP2014061270A JP2014061270A JP2014122240A5 JP 2014122240 A5 JP2014122240 A5 JP 2014122240A5 JP 2014061270 A JP2014061270 A JP 2014061270A JP 2014061270 A JP2014061270 A JP 2014061270A JP 2014122240 A5 JP2014122240 A5 JP 2014122240A5
Authority
JP
Japan
Prior art keywords
alkoxy
compound
disease
compound according
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014061270A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014122240A (ja
Filing date
Publication date
Priority claimed from US11/093,757 external-priority patent/US7582785B2/en
Application filed filed Critical
Publication of JP2014122240A publication Critical patent/JP2014122240A/ja
Publication of JP2014122240A5 publication Critical patent/JP2014122240A5/ja
Pending legal-status Critical Current

Links

JP2014061270A 2005-03-29 2014-03-25 トリヒドロキシポリ不飽和エイコサノイド誘導体 Pending JP2014122240A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/093,757 2005-03-29
US11/093,757 US7582785B2 (en) 2002-04-01 2005-03-29 Trihydroxy polyunsaturated eicosanoid derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012128022A Division JP2012162576A (ja) 2005-03-29 2012-06-05 トリヒドロキシポリ不飽和エイコサノイド誘導体

Publications (2)

Publication Number Publication Date
JP2014122240A JP2014122240A (ja) 2014-07-03
JP2014122240A5 true JP2014122240A5 (enExample) 2014-10-02

Family

ID=36645579

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008504239A Pending JP2008538117A (ja) 2005-03-29 2006-03-28 トリヒドロキシポリ不飽和エイコサノイド誘導体
JP2012128022A Pending JP2012162576A (ja) 2005-03-29 2012-06-05 トリヒドロキシポリ不飽和エイコサノイド誘導体
JP2014061270A Pending JP2014122240A (ja) 2005-03-29 2014-03-25 トリヒドロキシポリ不飽和エイコサノイド誘導体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008504239A Pending JP2008538117A (ja) 2005-03-29 2006-03-28 トリヒドロキシポリ不飽和エイコサノイド誘導体
JP2012128022A Pending JP2012162576A (ja) 2005-03-29 2012-06-05 トリヒドロキシポリ不飽和エイコサノイド誘導体

Country Status (9)

Country Link
US (1) US7582785B2 (enExample)
EP (1) EP1863753B1 (enExample)
JP (3) JP2008538117A (enExample)
CN (1) CN101203481A (enExample)
AU (1) AU2006230136B2 (enExample)
BR (1) BRPI0609767A2 (enExample)
CA (1) CA2603371C (enExample)
MX (2) MX2007012022A (enExample)
WO (1) WO2006105058A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL151299A0 (en) * 2000-02-16 2003-04-10 Brigham & Womens Hospital Aspirin-triggered lipid mediators
AU2002365167A1 (en) * 2001-12-18 2003-07-09 The Brigham And Women's Hospital Inhibition or prevention of infection by bacteria with epa, dha or analogs
US7582785B2 (en) * 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US8481772B2 (en) 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US7902257B2 (en) * 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
DK2216318T3 (en) * 2002-08-12 2018-12-10 Brigham & Womens Hospital Resolvins: Bio templates for therapeutic interventions
US7759395B2 (en) * 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
EP1755537A4 (en) * 2004-04-14 2009-12-09 Univ Boston METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
US7893106B2 (en) * 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
CA2588166A1 (en) * 2004-11-19 2006-05-26 Martek Biosciences Corporation Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
US20090318394A1 (en) * 2004-11-19 2009-12-24 Julie Nauroth Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
US20060293288A1 (en) * 2005-01-07 2006-12-28 Serhan Charles N Use of resolvins to treat gastrointestinal diseases
WO2007041440A2 (en) 2005-10-03 2007-04-12 The Brigham And Women's Hospital, Inc. Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers
WO2007061783A1 (en) * 2005-11-18 2007-05-31 Trustees Of Boston University Treatment and prevention of bone loss using resolvins
EP1983977A4 (en) * 2006-01-31 2011-11-30 Martek Biosciences Corp OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP2012828A2 (en) * 2006-04-28 2009-01-14 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treatment of cardiovascular disease
BRPI0714562A2 (pt) * 2006-07-19 2013-04-02 Resolvyx Pharmaceuticals Inc composiÇÕes e mÉtodos para o tratamento de mucosites
EP2131833A2 (en) * 2006-10-26 2009-12-16 Resolvyx Pharmaceuticals, Inc. Use of resolvins for inhibition of bone loss
US20080161275A1 (en) * 2006-12-05 2008-07-03 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treatment of inflammatory disease
EP2120920A4 (en) * 2007-02-20 2011-06-15 Martek Biosciences Corp OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
EP2207543A2 (en) * 2007-09-14 2010-07-21 Resolvyx Pharmaceuticals, Inc. Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function
CN103191129A (zh) * 2007-10-12 2013-07-10 C.T.辨析有限公司 治疗眼睛病症的脂氧化物类化合物
WO2009086281A1 (en) * 2007-12-21 2009-07-09 Martek Biosciences Corporation Method for preparation of oxylipins
WO2010039529A2 (en) * 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treament of inflammatory disease
EP2415748A4 (en) 2009-02-20 2013-08-07 Univ Tokyo NEW INFLAMMATORY COMPOUNDS
TW201039815A (en) * 2009-04-13 2010-11-16 Resolvyx Pharmaceuticals Inc Compositions and methods for the treatment of inflammation
JP5184565B2 (ja) * 2010-03-10 2013-04-17 独立行政法人科学技術振興機構 水系溶媒中での含窒素化合物の製造方法
CN103396350B (zh) * 2012-01-09 2014-11-05 浙江师范大学 一种利用顺式-1-卤-2-氯代烯烃合成维生素a的方法
PL2887923T3 (pl) 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
AU2014205369B2 (en) 2013-01-11 2018-08-09 Massachusetts Eye And Ear Infirmary CYP450 lipid metabolites reduce inflammation and angiogenesis
WO2014115098A1 (en) * 2013-01-26 2014-07-31 Mahesh Kandula Compositions and methods for the treatment of neurological diseases and inflammation
US9682034B2 (en) 2015-03-10 2017-06-20 Elc Management Llc Methods and compositions for treating skin to resolve inflammation and screening for actives that stimulate pro-resolution pathways
CN107438366B (zh) 2015-03-18 2022-03-15 福塞斯儿童牙科医院 使用脂氧素、消退素及其类似物稳定动脉粥状硬化斑块的方法
DK3373976T3 (da) 2015-11-10 2024-04-02 Sun Pharmaceutical Ind Ltd Topiske formuleringer og anvendelser deraf
WO2017091279A1 (en) * 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
EP3463419A4 (en) 2016-05-27 2020-03-25 Forsyth Dental Infirmary for Children COMPOSITIONS AND METHODS FOR TREATING CANCER USING LIPID AGONISTS AND RECEPTORS THEREOF
EP4107163A4 (en) 2020-02-21 2024-06-19 Retrotope, Inc. PROCESSES FOR ISOTOPIC MODIFICATION OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023A (en) * 1843-03-30 peters
GB2033745B (en) 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
US4567290A (en) * 1981-11-27 1986-01-28 Research Corporation Leukotriene analogues
US4442099A (en) * 1981-11-27 1984-04-10 Research Corporation Leukotriene analogues
US4576758A (en) * 1984-06-01 1986-03-18 The Upjohn Company Anti-inflammatory lipoxin B analogs
US4759880A (en) * 1984-09-27 1988-07-26 Research Corporation Alkanoarachidonic acids
US4710521A (en) * 1986-07-25 1987-12-01 The Celotex Corporation Catalyst mixtures for polyisocyanurate foam
US5136501A (en) * 1989-05-26 1992-08-04 Reuters Limited Anonymous matching system
EP0573423A4 (en) 1990-05-07 1994-06-01 Barry I Bockow Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
US5087790A (en) * 1991-06-12 1992-02-11 University Of Southern California Method for olefination of carbonyl compounds using titanocene derivatives
US5177046A (en) * 1991-09-20 1993-01-05 Air Products And Chemicals, Inc. Amine-boron adducts as reduced odor catalyst compositions for the production of polyurethanes
US5409955A (en) * 1993-05-13 1995-04-25 Bockow; Barry I. Compositions and methods for inhibiting uterine contractility
US6048897A (en) * 1993-06-15 2000-04-11 Brigham And Women's Hospital Lipoxin compounds and their use in treating cell proliferative disorders
US6030917A (en) * 1996-07-23 2000-02-29 Symyx Technologies, Inc. Combinatorial synthesis and analysis of organometallic compounds and catalysts
US5752238A (en) * 1994-11-03 1998-05-12 Intel Corporation Consumer-driven electronic information pricing mechanism
US5594732A (en) * 1995-03-03 1997-01-14 Intecom, Incorporated Bridging and signalling subsystems and methods for private and hybrid communications systems including multimedia systems
US5801280A (en) 1995-04-07 1998-09-01 Sumitomo Chemical Company, Limited Processes for preparing optically active alcohols and optically active amines
US5845265A (en) * 1995-04-26 1998-12-01 Mercexchange, L.L.C. Consignment nodes
US5756789A (en) * 1995-06-08 1998-05-26 Texaco, Inc. Synthesis of metal--containing aluminophosphates with layered structure
AU1122997A (en) 1995-11-07 1997-06-11 Cadis, Inc. Search engine for remote object oriented database management system
US5870717A (en) * 1995-11-13 1999-02-09 International Business Machines Corporation System for ordering items over computer network using an electronic catalog
US5995943A (en) 1996-04-01 1999-11-30 Sabre Inc. Information aggregation and synthesization system
US5878400A (en) * 1996-06-17 1999-03-02 Trilogy Development Group, Inc. Method and apparatus for pricing products in multi-level product and organizational groups
US5842040A (en) * 1996-06-18 1998-11-24 Storage Technology Corporation Policy caching method and apparatus for use in a communication device based on contents of one data unit in a subset of related data units
US6232467B1 (en) * 1996-06-28 2001-05-15 University Of Southern California Method for the synthesis of amines and amino acids with organoboron derivatives
US6602817B1 (en) * 1998-10-23 2003-08-05 University Of Southern California Combination approach to chiral reagents or catalysts having amine or amino alcohol ligands
US5890138A (en) * 1996-08-26 1999-03-30 Bid.Com International Inc. Computer auction system
US5861399A (en) * 1996-07-17 1999-01-19 Heart Care Partners Methods and compositions for the rapid and enduring relief of inadequate myocardial function
US5896379A (en) * 1996-08-26 1999-04-20 Motorola, Inc. Network node for packet switching with selective data processing and method therefor
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
US5946467A (en) * 1996-09-20 1999-08-31 Novell, Inc. Application-level, persistent packeting apparatus and method
US20020055539A1 (en) * 1996-10-02 2002-05-09 Bockow Barry I. Compositions and methods for treating cardiovascular conditions
AU4996997A (en) 1996-10-25 1998-05-22 Ipf, Inc. System and method for managing and serving consumer product related information over the internet
JPH10152448A (ja) * 1996-11-20 1998-06-09 Fuji Photo Film Co Ltd 不飽和化合物の水素化方法および重水素化方法
WO1998046588A2 (en) 1997-04-11 1998-10-22 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US5878423A (en) * 1997-04-21 1999-03-02 Bellsouth Corporation Dynamically processing an index to create an ordered set of questions
US6006264A (en) 1997-08-01 1999-12-21 Arrowpoint Communications, Inc. Method and system for directing a flow between a client and a server
US6038668A (en) 1997-09-08 2000-03-14 Science Applications International Corporation System, method, and medium for retrieving, organizing, and utilizing networked data
US6030715A (en) * 1997-10-09 2000-02-29 The University Of Southern California Azlactone-related dopants in the emissive layer of an OLED
US6259699B1 (en) * 1997-12-30 2001-07-10 Nexabit Networks, Llc System architecture for and method of processing packets and/or cells in a common switch
AU3843999A (en) 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
US6377937B1 (en) * 1998-05-28 2002-04-23 Paskowitz Associates Method and system for more effective communication of characteristics data for products and services
US6069109A (en) * 1998-07-01 2000-05-30 Union Carbide Chemicals & Plastics Technology Corporation Process for the production of half-sandwich transition metal based catalyst precursors
US6336138B1 (en) * 1998-08-25 2002-01-01 Hewlett-Packard Company Template-driven approach for generating models on network services
US6336105B1 (en) * 1998-11-16 2002-01-01 Trade Access Inc. System and method for representing data and providing electronic non-repudiation in a negotiations system
DE19855426A1 (de) 1998-12-02 2000-06-08 Wolfgang Langhoff Mittel zur Therapie und Prophylaxe von rheumatisch-arthritischen Erkrankungen und zur Prophylaxe von cardiovaskulären Erkrankungen
US6272474B1 (en) * 1999-02-08 2001-08-07 Crisostomo B. Garcia Method for monitoring and trading stocks via the internet displaying bid/ask trade bars
US6397212B1 (en) * 1999-03-04 2002-05-28 Peter Biffar Self-learning and self-personalizing knowledge search engine that delivers holistic results
US6427132B1 (en) * 1999-08-31 2002-07-30 Accenture Llp System, method and article of manufacture for demonstrating E-commerce capabilities via a simulation on a network
US6415270B1 (en) * 1999-09-03 2002-07-02 Omnihub, Inc. Multiple auction coordination method and system
IL151299A0 (en) * 2000-02-16 2003-04-10 Brigham & Womens Hospital Aspirin-triggered lipid mediators
DE10049271A1 (de) * 2000-09-28 2002-04-11 Basf Ag Verfahren zur katalytischen Reduktion von Alkinverbindungen
AU2002365167A1 (en) * 2001-12-18 2003-07-09 The Brigham And Women's Hospital Inhibition or prevention of infection by bacteria with epa, dha or analogs
US6949664B2 (en) * 2002-04-01 2005-09-27 University Of Southern California Trihydroxy polyunsaturated eicosanoids
US7582785B2 (en) * 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US7378444B2 (en) * 2002-06-17 2008-05-27 Brigham And Women's Hospital, Inc. Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
US7759395B2 (en) * 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
DK2216318T3 (en) * 2002-08-12 2018-12-10 Brigham & Womens Hospital Resolvins: Bio templates for therapeutic interventions
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
US20060293288A1 (en) * 2005-01-07 2006-12-28 Serhan Charles N Use of resolvins to treat gastrointestinal diseases
CN103191129A (zh) * 2007-10-12 2013-07-10 C.T.辨析有限公司 治疗眼睛病症的脂氧化物类化合物
WO2010039531A1 (en) * 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Therapeutic compounds
US20120122816A1 (en) * 2009-02-05 2012-05-17 Resolvyx Pharmaceuticals, Inc. Compositions and methods for organ preservation
TW201039815A (en) * 2009-04-13 2010-11-16 Resolvyx Pharmaceuticals Inc Compositions and methods for the treatment of inflammation

Similar Documents

Publication Publication Date Title
JP2016527382A5 (enExample)
HUS2200011I1 (hu) Készítmények és eljárások HAO1 (hidroxisav-oxidáz-1 (glikolát-oxidáz)) gén expressziójának gátlására
EP4588928A3 (en) Methods for treating filoviridae virus infections
EA201692537A1 (ru) Замещенные нуклеозиды, нуклеотиды и их аналоги
SG11201700944RA (en) Microrna biomarker for the diagnosis of gastric cancer
MX2018010924A (es) Células efectoras inmunitarias con edición genómica.
CU24435B1 (es) Compuesto de (pirazolilamino) pirimidinil biciclo (3.2.1)oct-8-il
EP3398916A4 (en) PHOSPHORYLATED POLYCONDENSATE AS A HIGHLY EFFICIENT WATER REDUCING AGENT AND METHOD OF MANUFACTURING THEREOF
DK3317415T3 (da) UTR'er, som forøger translationseffektiviteten for RNA-molekyler
WO2015195656A3 (en) Synthesis of polycyclic-carbamoylpyridone compounds
SI2820009T1 (en) Serine / Threonine kinase inhibitors
EP3219707A3 (en) Process for the preparation of substituted oxiranes and triazoles
WO2016086036A3 (en) Methods and compositions for 18f-radiolabeling of biologics
IL258149B (en) Aggregate galnac phosphoramidite
FR3016889B1 (fr) Procede de reaslisation par ald d'une couche mince de formule myx
IL256528B (en) Processes for the preparation of galnac acid hist
PL3234201T3 (pl) Sposób wytwarzania stałych sacharydów z wodnego roztworu sacharydów
JP2017500407A5 (enExample)
FR3029576B1 (fr) Procede pour reduire le niveau de bruit d'une soufflante de turbomachine
FR3033682B1 (fr) Procede de preparation d'un extrait de plante par extrusion avec une solution hydrotropique
EP3332633A4 (en) PLANT WITH MUTED CYCLIN-F-BOX-GEN
EP3628374A3 (en) Bcl-3 inhibitors
BR112013017568A2 (pt) membro de regulagem de fluxo de tanque de revestimento com imersão a quente e sistema de revestimento com imersão a quente contínuo
JP2018531301A5 (enExample)
EP3365819A4 (en) PHARMACOPHORS, COMPOUNDS AND METHODS USED IN THE TREATMENT OF CANCER BY INHIBITION OF CYP17A1 AND CYP19A1